DOCSLIB.ORG

Supplementary Table 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 2 Ayrault et al. Supplementary Table S2 Term Count % PValue GO:0007155~cell adhesion 55 13.06% 3.97E-15 1417231_at Cldn2 11.31 CLAUDIN 2 1418153_at Lama1 8.17 LAMININ, ALPHA 1 1434601_at Amigo2 7.78 ADHESION MOLECULE WITH IG LIKE DOMAIN 2 1456214_at Pcdh7 7.26 PROTOCADHERIN 7 1437442_at Pcdh7 6.41 PROTOCADHERIN 7 1445256_at Vcl 6.36 VINCULIN 1427009_at Lama5 5.7 LAMININ, ALPHA 5 1453070_at Pcdh17 5.17 PROTOCADHERIN 17 1428571_at Col9a1 4.59 PROCOLLAGEN, TYPE IX, ALPHA 1 1416039_x_at Cyr61 4.56 CYSTEINE RICH PROTEIN 61 1437932_a_at Cldn1 4.53 CLAUDIN 1 1456397_at Cdh4 4.44 CADHERIN 4 1427010_s_at Lama5 4.23 LAMININ, ALPHA 5 1449422_at Cdh4 3.71 CADHERIN 4 1452784_at Itgav 3.01 INTEGRIN ALPHA V 1435603_at Sned1 2.87 SUSHI, NIDOGEN AND EGF-LIKE DOMAINS 1 1438928_x_at Ninj1 2.85 NINJURIN 1 1441498_at Ptprd 2.69 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, D 1419632_at Tecta -33.82 TECTORIN ALPHA 1455056_at Lmo7 -14.83 LIM DOMAIN ONLY 7 1450637_a_at Aebp1 -10.7 AE BINDING PROTEIN 1 1421811_at Thbs1 -10.27 THROMBOSPONDIN 1 1434667_at Col8a2 -8.51 PROCOLLAGEN, TYPE VIII, ALPHA 2 1418304_at Pcdh21 -7.26 PROTOCADHERIN 21 1451454_at Pcdh20 -6.63 PROTOCADHERIN 20 1424701_at Pcdh20 -6.54 PROTOCADHERIN 20 1451758_at Lamc3 -6.15 LAMININ GAMMA 3 1422514_at Aebp1 -5.74 AE BINDING PROTEIN 1 1422694_at Ttyh1 -5.62 TWEETY HOMOLOG 1 (DROSOPHILA) 1425594_at Lamc3 -5.43 LAMININ GAMMA 3 1431152_at Hapln3 -5.39 HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 3 1418424_at Tnfaip6 -5.17 TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6 1451769_s_at Pcdha4;pcdha10;pcdha1;pcdha2;pcdhac1;pcdha6;pcdha8;pcdhac2;pcdha5;pcdha7;pcdha9;pcdha12;pcdha3-4.99 PROTOCADHERIN ALPHA 4;PROTOCADHERIN ALPHA 14;PROTOCADHERIN ALPHA 1;PROTOCADHERIN ALPHA 2;PROTOCADHERIN ALPHA SUBFAMILY C 1423669_at Col1a1 -4.63 PROCOLLAGEN, TYPE I, ALPHA 1 1435165_at Cntn2 -4.59 CONTACTIN 2 1426348_at Col4a1 -4.5 PROCOLLAGEN, TYPE IV, ALPHA 1 1422695_at Ttyh1;taf1 -4.38 TWEETY HOMOLOG 1 (DROSOPHILA);TAF1 RNA POLYMERASE II, TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR 1452250_a_at Col6a2 -4.32 PROCOLLAGEN, TYPE VI, ALPHA 2 1415855_at Kitl -4.26 KIT LIGAND 1424341_s_at Pcdha12;pcdha6;pcdha4;pcdhac2;pcdha8;pcdha2;pcdha7;pcdha9;pcdha5;pcdha1;pcdha10;pcdhac1;pcdha3-4.17 PROTOCADHERIN ALPHA 13;PROTOCADHERIN ALPHA 6;PROTOCADHERIN ALPHA 4;PROTOCADHERIN ALPHA SUBFAMILY C 1424051_at Col4a2 -4 PROCOLLAGEN, TYPE IV, ALPHA 2 1450435_at L1cam -3.78 L1 CELL ADHESION MOLECULE 1420429_at Pcdhb3 -3.73 PROTOCADHERIN BETA 3 1450625_at Col5a2 -3.61 PROCOLLAGEN, TYPE V, ALPHA 2 1440311_at Sorbs1 -3.61 SORBIN AND SH3 DOMAIN CONTAINING 1 1437787_at Lrrtm2;ctnna1 -3.43 LEUCINE RICH REPEAT TRANSMEMBRANE NEURONAL 2;CATENIN (CADHERIN ASSOCIATED PROTEIN), ALPHA 1 1418393_a_at Itga7 -3.18 INTEGRIN ALPHA 7 1456962_at Cntn2 -3.12 CONTACTIN 2 1444020_at Ncan -3.03 CHONDROITIN SULFATE PROTEOGLYCAN 3 1434679_at Ncan -2.99 CHONDROITIN SULFATE PROTEOGLYCAN 3 1419573_a_at Lgals1 -2.57 LECTIN, GALACTOSE BINDING, SOLUBLE 1 1422437_at Col5a2 -2.48 PROCOLLAGEN, TYPE V, ALPHA 2 1434709_at Nrcam -2.48 RIKEN CDNA C030017F07 GENE 1433451_at Cdk5r1 -2.46 CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT (P35) 1 1455439_a_at Lgals1 -2.41 LECTIN, GALACTOSE BINDING, SOLUBLE 1 GO:0009653~anatomical structure morphogenesis 61 14.49% 2.44E-08 1450042_at Arx 584.07 ARISTALESS RELATED HOMEOBOX GENE (DROSOPHILA) 1425452_s_at Ptprj;aw125753 127.12 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, J;RIKEN CDNA 4731402F03 GENE 1425452_s_at Ptprj;aw125753 127.12 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, J;RIKEN CDNA 4731402F03 GENE 1457018_at Kcnma1 18.13 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1424848_at Kcnma1 18.13 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1444973_at Kcnma1 13.74 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1445774_at Kcnma1 12.47 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1440728_at Kcnma1 11.88 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1429974_at Tbx18 11.39 T-BOX18 1438303_at Tgfb2 11 TRANSFORMING GROWTH FACTOR, BETA 2 1450922_a_at Tgfb2 9.45 TRANSFORMING GROWTH FACTOR, BETA 2 1418153_at Lama1 8.17 LAMININ, ALPHA 1 1445256_at Vcl 6.36 VINCULIN 1449058_at Gli1 5.78 GLI-KRUPPEL FAMILY MEMBER GLI1 1427009_at Lama5 5.7 LAMININ, ALPHA 5 1423250_a_at Tgfb2 5.62 TRANSFORMING GROWTH FACTOR, BETA 2 1450923_at Tgfb2 4.92 TRANSFORMING GROWTH FACTOR, BETA 2 1416039_x_at Cyr61 4.56 CYSTEINE RICH PROTEIN 61 1460343_at Neurl 4.5 NEURALIZED-LIKE HOMOLOG (DROSOPHILA) 1425987_a_at Kcnma1 4.5 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1456397_at Cdh4 4.44 CADHERIN 4 1446141_at Tgfb2 4.44 TRANSFORMING GROWTH FACTOR, BETA 2 1422789_at Aldh1a2 4.38 ALDEHYDE DEHYDROGENASE FAMILY 1, SUBFAMILY A2 1427010_s_at Lama5 4.23 LAMININ, ALPHA 5 1418892_at Rhoj 4.2 RIKEN CDNA 1110005O19 GENE 1420653_at Tgfb1 3.94 TRANSFORMING GROWTH FACTOR, BETA 1 1418711_at Pdgfa 3.86 PLATELET DERIVED GROWTH FACTOR, ALPHA 1437284_at Fzd1 3.78 FRIZZLED HOMOLOG 1 (DROSOPHILA) 1425923_at Mycn 3.76 V-MYC MYELOCYTOMATOSIS VIRAL RELATED ONCOGENE, NEUROBLASTOMA DERIVED (AVIAN) 1449422_at Cdh4 3.71 CADHERIN 4 1456854_at Neurl 3.71 NEURALIZED-LIKE HOMOLOG (DROSOPHILA) 1419123_a_at Pdgfc 3.34 PLATELET-DERIVED GROWTH FACTOR, C POLYPEPTIDE 1446086_s_at Gli2 3.32 GLI-KRUPPEL FAMILY MEMBER GLI2 1418220_at Foxf2 3.2 FORKHEAD BOX F2 1422833_at Foxa2 3.2 FORKHEAD BOX A2 1433825_at Ntrk3 3.14 NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3 1452784_at Itgav 3.01 INTEGRIN ALPHA V 1438928_x_at Ninj1 2.85 NINJURIN 1 1459211_at Gli2 2.85 GLI-KRUPPEL FAMILY MEMBER GLI2 1420824_at Sema4d 2.69 SEMA DOMAIN, IMMUNOGLOBULIN DOMAIN (IG), TRANSMEMBRANE DOMAIN (TM) AND SHORT CYTOPLASMIC DOMAIN, (SEMAPHORIN) 4D 1449187_at Pdgfa 2.45 PLATELET DERIVED GROWTH FACTOR, ALPHA 1423227_at Krt17 -57.68 KERATIN COMPLEX 1, ACIDIC, GENE 17 1456781_at Sox2 -25.46 SRY-BOX CONTAINING GENE 2 1418876_at Foxd1 -25.46 FORKHEAD BOX D1 1423377_at Igfbpl1 -14.72 IGFBP-LIKE PROTEIN 1424704_at Runx2 -11.24 RUNT RELATED TRANSCRIPTION FACTOR 2 1421811_at Thbs1 -10.27 THROMBOSPONDIN 1 1434667_at Col8a2 -8.51 PROCOLLAGEN, TYPE VIII, ALPHA 2 1450960_at Igfbpl1 -8.11 IGFBP-LIKE PROTEIN 1419383_at S100b -7.94 S100 PROTEIN, BETA POLYPEPTIDE, NEURAL 1434342_at S100b -7.57 S100 PROTEIN, BETA POLYPEPTIDE, NEURAL 1421524_at Cfc1 -7.21 CRIPTO, FRL-1, CRYPTIC FAMILY 1 1418950_at Drd2 -6.77 DOPAMINE RECEPTOR 2 1416967_at Sox2 -6.28 SRY-BOX CONTAINING GENE 2 1450708_at Scg2 -6.23 SECRETOGRANIN II 1422694_at Ttyh1 -5.62 TWEETY HOMOLOG 1 (DROSOPHILA) 1422520_at Nefm -5.54 NEUROFILAMENT 3, MEDIUM 1437800_at Edaradd -4.59 RIKEN CDNA 1810032E07 GENE 1449281_at Nrtn -4.44 NEURTURIN 1419639_at Efnb2 -4.38 EPHRIN B2 1422695_at Ttyh1;taf1 -4.38 TWEETY HOMOLOG 1 (DROSOPHILA);TAF1 RNA POLYMERASE II, TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR 1449135_at Sox18 -4.35 SRY-BOX CONTAINING GENE 18 1446127_at Zeb1 -4.32 ZINC FINGER HOMEOBOX 1A 1456686_at Zeb1 -4.29 ZINC FINGER HOMEOBOX 1A 1434413_at Igf1 -4.06 INSULIN-LIKE GROWTH FACTOR 1 1424051_at Col4a2 -4 PROCOLLAGEN, TYPE IV, ALPHA 2 1450435_at L1cam -3.78 L1 CELL ADHESION MOLECULE 1436499_at Sgms1 -3.61 TRANSMEMBRANE PROTEIN 23 1437787_at Lrrtm2;ctnna1 -3.43 LEUCINE RICH REPEAT TRANSMEMBRANE NEURONAL 2;CATENIN (CADHERIN ASSOCIATED PROTEIN), ALPHA 1 1418634_at Notch1 -3.36 NOTCH GENE HOMOLOG 1 (DROSOPHILA) 1423756_s_at Igfbp4 -3.32 INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4 1419666_x_at Nupr1 -3.25 NUCLEAR PROTEIN 1 1418393_a_at Itga7 -3.18 INTEGRIN ALPHA 7 1449822_at Atoh1 -3.07 ATONAL HOMOLOG 1 (DROSOPHILA) 1437405_a_at Igfbp4 -2.93 INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4 1418926_at Zeb1 -2.62 ZINC FINGER HOMEOBOX 1A 1434709_at Nrcam -2.48 RIKEN CDNA C030017F07 GENE 1433451_at Cdk5r1 -2.46 CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT (P35) 1 1418141_at Dcx -2.43 DOUBLECORTIN 1428374_at Glce -2.43 RIKEN CDNA 1110017N23 GENE 1416683_at Plxnb2 -2.38 PLEXIN B2 1421917_at Pdgfra -2.31 PLATELET DERIVED GROWTH FACTOR RECEPTOR, ALPHA POLYPEPTIDE GO:0048856~anatomical structure development 87 20.67% 6.75E-08 1450042_at Arx 584.07 ARISTALESS RELATED HOMEOBOX GENE (DROSOPHILA) 1425452_s_at Ptprj;aw125753 127.12 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, J;RIKEN CDNA 4731402F03 GENE 1425452_s_at Ptprj;aw125753 127.12 PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, J;RIKEN CDNA 4731402F03 GENE 1457018_at Kcnma1 18.13 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1424848_at Kcnma1 18.13 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1444973_at Kcnma1 13.74 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1445774_at Kcnma1 12.47 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1440728_at Kcnma1 11.88 POTASSIUM LARGE CONDUCTANCE CALCIUM-ACTIVATED CHANNEL, SUBFAMILY M, ALPHA MEMBER 1 1429974_at Tbx18 11.39 T-BOX18 1438303_at Tgfb2 11 TRANSFORMING GROWTH FACTOR, BETA 2 1450922_a_at Tgfb2 9.45 TRANSFORMING GROWTH FACTOR, BETA 2 1418153_at Lama1 8.17 LAMININ, ALPHA 1 1455647_at Ar 6.92 ANDROGEN RECEPTOR 1445256_at Vcl 6.36 VINCULIN 1437904_at Rbm45 5.9 DEVELOPMENTALLY REGULATED RNA BINDING PROTEIN 1 1449058_at Gli1 5.78 GLI-KRUPPEL FAMILY MEMBER GLI1 1427009_at Lama5 5.7 LAMININ, ALPHA 5 1423250_a_at Tgfb2 5.62 TRANSFORMING GROWTH FACTOR, BETA 2 1444286_at Otp 5.31 ORTHOPEDIA HOMOLOG (DROSOPHILA) 1450923_at Tgfb2 4.92 TRANSFORMING GROWTH FACTOR, BETA
Load more

Recommended publications
  • Hedgehog Signaling Is Evolutionarily Conserved Cilium-Independent
    Downloaded from genesdev.cshlp.org on August 14, 2009 - Published by Cold Spring Harbor Laboratory Press Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved Miao-Hsueh Chen, Christopher W. Wilson, Ya-Jun Li, et al. Genes Dev. 2009 23: 1910-1928 Access the most recent version at doi:10.1101/gad.1794109 Supplemental http://genesdev.cshlp.org/content/suppl/2009/07/23/23.16.1910.DC1.html Material References This article cites 97 articles, 47 of which can be accessed free at: http://genesdev.cshlp.org/content/23/16/1910.full.html#ref-list-1 Email alerting Receive free email alerts when new articles cite this article - sign up in the box at the service top right corner of the article or click here To subscribe to Genes & Development go to: http://genesdev.cshlp.org/subscriptions Copyright © 2009 by Cold Spring Harbor Laboratory Press Downloaded from genesdev.cshlp.org on August 14, 2009 - Published by Cold Spring Harbor Laboratory Press Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved Miao-Hsueh Chen,1,3 Christopher W. Wilson,1,3 Ya-Jun Li,1 Kelvin King Lo Law,2 Chi-Sheng Lu,1 Rhodora Gacayan,1 Xiaoyun Zhang,2 Chi-chung Hui,2 and Pao-Tien Chuang1,4 1Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94158, USA; 2Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1L7, Canada A central question in Hedgehog (Hh) signaling is how evolutionarily conserved components of the pathway might use the primary cilium in mammals but not fly.
    [Show full text]
  • Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis*
    crossmark THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 291, NO. 49, pp. 25749–25760, December 2, 2016 © 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis*□S Received for publication, August 12, 2016, and in revised form, September 28, 2016 Published, JBC Papers in Press, October 19, 2016, DOI 10.1074/jbc.M116.753129 Meng Wu‡, Lishann Ingram‡, Ezequiel J. Tolosa§, Renzo E. Vera§, Qianjin Li‡, Sungjin Kim‡, Yongjie Ma‡, Demetri D. Spyropoulos¶, Zanna Beharryʈ, Jiaoti Huang**, Martin E. Fernandez-Zapico§, and Houjian Cai‡1 From the ‡Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, the §Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, the ¶Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, the ʈDepartment of Chemistry and Physics, Florida Gulf Coast University, Fort Myers, Florida 33965, and the **Department of Pathology, School of Medicine, Duke University, Durham, North Carolina 27710 Edited by Eric Fearon Although the differentiation of oncogenically transformed cer progression has been characterized with multiple stages, 2 basal progenitor cells is one of the key steps in prostate tumori- including benign, prostatic intraepithelial neoplasia (PIN), Downloaded from genesis, the mechanisms mediating this cellular process are still invasive adenocarcinoma, and metastatic cancer (2). Numerous ؉ largely unknown. Here we demonstrate that an expanded p63 oncogenic driver genes, including loss of tumor suppressors, ؉ and CK5 basal/progenitor cell population, induced by the con- overexpression, and/or activation of oncogenes, have been comitant activation of oncogenic Kras(G12D) and androgen identified based on genetic analysis of clinical prostate tumors.
    [Show full text]
  • Mutations in EDA and EDAR Genes in a Large Mexican Hispanic Cohort with Hypohidrotic Ectodermal Dysplasia
    Letter to the Editor http://dx.doi.org/10.5021/ad.2015.27.4.474 Mutations in EDA and EDAR Genes in a Large Mexican Hispanic Cohort with Hypohidrotic Ectodermal Dysplasia Julio C Salas-Alanis1,2, Eva Wozniak3, Charles A Mein3, Carola C Duran Mckinster4, Jorge Ocampo-Candiani1, David P Kelsell5, Rong Hua6, Maria L Garza-Rodriguez7, Keith A Choate6, Hugo A Barrera Saldaña7,8 1Dermatology Department, Hospital Universitario, Universidad Autonoma de Nuevo Leon, 2Basic Science Department, Medicine School, Universidad de Monterrey, Monterrey, NL, Mexico, 3Barts and the London Genome Centre, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, University of London, London, United Kingdom, 4Instituto Nacional de Pediatria, Coyoacan, CP, Mexico, 5Centre for Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 6Departments of Dermatology, Genetics, and Pathology, Yale University School of Medicine, New Haven, CT, USA, 7Facultad de Medicina, Departamento de Bioquímica y Medicina Molecular, Universidad Autonoma de Nuevo Leon,8Vitagenesis, Monterrey, NL, Mexico Dear Editor: cludes dryness of the skin, eyes, airways, and mucous Ectodermal dysplasias (ED) encompass nearly 200 differ- membranes, as well as other ectodermal defects and, in ent genetic conditions identified by the lack, or dysgenesis, some cases, fever, seizures, and rarely, death. of at least two ectodermal derivatives, such as hair, nails, XL-HED is caused by mutations in the EDA gene, located teeth, and sweat glands. Hypohidrotic/anhidrotic ED (HED) on chromosome Xq12-q13.1, which encodes a signaling is the most frequent form of ED and it can be inherited as molecule of the tumor necrosis factor (TNF) superfamily.
    [Show full text]
  • Temporary Disruption of the Retinal Basal Lamina and Its Effect on Retinal Histogenesis
    Developmental Biology 238, 79–96 (2001) doi:10.1006/dbio.2001.0396, available online at http://www.idealibrary.com on Temporary Disruption of the Retinal Basal Lamina and Its Effect on Retinal Histogenesis Willi Halfter,*,1 Sucai Dong,* Manimalha Balasubramani,* and Mark E. Bier† *Department of Neurobiology, University of Pittsburgh, 1402 E Biological Science Tower, Pittsburgh, Pennsylvania 15261; and †Department of Chemistry, Mellon Institute, Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, Pennsylvania 15213-2683 An experimental paradigm was devised to remove the retinal basal lamina for defined periods of development: the basal lamina was dissolved by injecting collagenase into the vitreous of embryonic chick eyes, and its regeneration was induced by a chase with mouse laminin-1 and ␣2-macroglobulin. The laminin-1 was essential in reconstituting a new basal lamina and could not be replaced by laminin-2 or collagen IV, whereas the macroglobulin served as a collagenase inhibitor that did not directly contribute to basal lamina regeneration. The regeneration occurred within 6 h after the laminin-1 chase by forming a morphologically complete basal lamina that included all known basal lamina proteins from chick embryos, such as laminin-1, nidogen-1, collagens IV and XVIII, perlecan, and agrin. The temporary absence of the basal lamina had dramatic effects on retinal histogenesis, such as an irreversible retraction of the endfeet of the neuroepithelial cells from the vitreal surface of the retina, the formation of a disorganized ganglion cell layer with an increase in ganglion cells by 30%, and the appearance of multiple retinal ectopias. Finally, basal lamina regeneration was associated with aberrant axons failing to correctly enter the optic nerve.
    [Show full text]
  • Non-Canonical Activation of Hedgehog in Prostate Cancer Cells Mediated by the Interaction of Transcriptionally Active Androgen Receptor Proteins with Gli3
    Oncogene (2018) 37:2313–2325 https://doi.org/10.1038/s41388-017-0098-7 ARTICLE Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3 1 1,2 2 1 1 1 2,3 Na Li ● Sarah Truong ● Mannan Nouri ● Jackson Moore ● Nader Al Nakouzi ● Amy Anne Lubik ● Ralph Buttyan Received: 19 July 2017 / Revised: 18 October 2017 / Accepted: 29 November 2017 / Published online: 12 February 2018 © The Author(s) 2018. This article is published with open access Abstract Hedgehog (Hh) is an oncogenic signaling pathway that regulates the activity of Gli transcription factors. Canonical Hh is a Smoothened-(Smo-) driven process that alters the post-translational processing of Gli2/Gli3 proteins. Though evidence supports a role for Gli action in prostate cancer (PCa) cell growth and progression, there is little indication that Smo is involved. Here we describe a non-canonical means for activation of Gli transcription in PCa cells mediated by the binding of transcriptionally-active androgen receptors (ARs) to Gli3. Androgens stimulated reporter expression from a Gli-dependent promoter in a variety of AR + PCa cells and this activity was suppressed by an anti-androgen, Enz, or by AR knockdown. 1234567890();,: Androgens also upregulated expression of endogenous Gli-dependent genes. This activity was associated with increased intranuclear binding of Gli3 to AR that was antagonized by Enz. Fine mapping of the AR binding domain on Gli2 showed that AR recognizes the Gli protein processing domain (PPD) in the C-terminus. Mutations in the arginine-/serine repeat elements of the Gli2 PPD involved in phosphorylation and ubiquitinylation blocked the binding to AR.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Targeting the Tryptophan Hydroxylase 2 Gene for Functional Analysis in Mice and Serotonergic Differentiation of Embryonic Stem Cells
    TARGETING THE TRYPTOPHAN HYDROXYLASE 2 GENE FOR FUNCTIONAL ANALYSIS IN MICE AND SEROTONERGIC DIFFERENTIATION OF EMBRYONIC STEM CELLS Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by Dana Kikic, M.Sc. in Molecular biology and Physiology from Nis June, 2009 The doctorate studies were performed in the research group of Prof. Michael Bader Molecular Biology of Peptide Hormones at Max-Delbrück-Center for Molecular Medicine in Berlin, Buch Mai 2005 - September 2008. 1st Reviewer: Prof. Michael Bader 2nd Reviewer: Prof. Udo Heinemann date of defence: 13. August 2009 ACKNOWLEDGMENTS Herewith, I would like to acknowledge the persons who made this thesis possible and without whom my initiation in the world of basic science research would not have the spin it has now, neither would my scientific illiteracy get the chance to eradicate. I am expressing my very personal gratitude and recognition to: Prof. Michael Bader, for an inexhaustible guidance in all the matters arising during the course of scientific work, for an instinct in defining and following the intellectual challenge and for letting me following my own, for necessary financial support, for defining the borders of reasonable and unreasonable, for an invaluable time and patience, and an amazing efficiency in supporting, motivating, reading, correcting and shaping my scientific language during the last four years. Prof. Harald Saumweber and Prof. Udo Heinemann, for taking over the academic supervision of the thesis, and for breathing in it a life outside the laboratory walls and their personal signature.
    [Show full text]
  • In Normal Conditions After Heat Stress
    1 Transcriptome analysis of yamame (Oncorhynchus masou) in normal conditions after heat stress Waraporn Kraitavin1, Kazutoshi Yoshitake1, Yoji Igarashi1, Susumu Mitsuyama1, Shigeharu Kinoshita1, Daisuke Kambayashi2, Shugo Watabe3 and Shuichi Asakawa1* 1 Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo, Tokyo 113-8657, Japan; [email protected] (S.A.) 2 Kobayashi Branch, Miyazaki Prefectural Fisheries Research Institute, Kobayashi, Miyazaki 886-0005, Japan 3 School of Marine Biosciences, Kitasato University, Minami, Sagamihara, Kanagawa 252-0313, Japan; [email protected] * Correspondence: [email protected] (S.A.) 2 A B *HT represents high-temperature tolerant, NT represents non-high-temperature tolerant Figure S1. The pheatmap repeatability analysis of mRNA libraries between samples using the Pearson correlation, (A) gill and (B) fin 3 A B *HT represents high-temperature tolerant, NT represents non-high-temperature tolerant Figure S2. The PCA analysis of mRNA libraries between samples, (A) gill and (B) fin. 4 Table S1. List of the differentially expressed genes of the gill in yamame Gene_id Annotation HT_TPM NT_TPM log2(FoldChange) P - value TRINITY_DN100000_c0_g1_i2 VDAC2 27.57 17.15 0.71 0.00 TRINITY_DN100006_c4_g1_i1 0.65 2.69 -1.93 0.00 TRINITY_DN100021_c0_g1_i2 CXL14 0.13 4.06 -4.96 0.00 TRINITY_DN100027_c4_g2_i1 PEAK1 1.31 4.44 -1.77 0.00 TRINITY_DN100027_c4_g3_i1 0.17 2.38 -3.18 0.00 TRINITY_DN100035_c6_g6_i2 2.13 13.97 -2.68 0.00 TRINITY_DN100055_c1_g2_i1 3BHS 0.22
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Supp Table 1.Pdf
    Upregulated genes in Hdac8 null cranial neural crest cells fold change Gene Symbol Gene Title 134.39 Stmn4 stathmin-like 4 46.05 Lhx1 LIM homeobox protein 1 31.45 Lect2 leukocyte cell-derived chemotaxin 2 31.09 Zfp108 zinc finger protein 108 27.74 0710007G10Rik RIKEN cDNA 0710007G10 gene 26.31 1700019O17Rik RIKEN cDNA 1700019O17 gene 25.72 Cyb561 Cytochrome b-561 25.35 Tsc22d1 TSC22 domain family, member 1 25.27 4921513I08Rik RIKEN cDNA 4921513I08 gene 24.58 Ofa oncofetal antigen 24.47 B230112I24Rik RIKEN cDNA B230112I24 gene 23.86 Uty ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome 22.84 D8Ertd268e DNA segment, Chr 8, ERATO Doi 268, expressed 19.78 Dag1 Dystroglycan 1 19.74 Pkn1 protein kinase N1 18.64 Cts8 cathepsin 8 18.23 1500012D20Rik RIKEN cDNA 1500012D20 gene 18.09 Slc43a2 solute carrier family 43, member 2 17.17 Pcm1 Pericentriolar material 1 17.17 Prg2 proteoglycan 2, bone marrow 17.11 LOC671579 hypothetical protein LOC671579 17.11 Slco1a5 solute carrier organic anion transporter family, member 1a5 17.02 Fbxl7 F-box and leucine-rich repeat protein 7 17.02 Kcns2 K+ voltage-gated channel, subfamily S, 2 16.93 AW493845 Expressed sequence AW493845 16.12 1600014K23Rik RIKEN cDNA 1600014K23 gene 15.71 Cst8 cystatin 8 (cystatin-related epididymal spermatogenic) 15.68 4922502D21Rik RIKEN cDNA 4922502D21 gene 15.32 2810011L19Rik RIKEN cDNA 2810011L19 gene 15.08 Btbd9 BTB (POZ) domain containing 9 14.77 Hoxa11os homeo box A11, opposite strand transcript 14.74 Obp1a odorant binding protein Ia 14.72 ORF28 open reading
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]